189 related articles for article (PubMed ID: 38527429)
21. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance.
Fatma H; Maurya SK; Siddique HR
Semin Cancer Biol; 2022 Aug; 83():166-176. PubMed ID: 33220458
[TBL] [Abstract][Full Text] [Related]
22. Limitations of current
Rogers HA; Chapman R; Kings H; Allard J; Barron-Hastings J; Pajtler KW; Sill M; Pfister S; Grundy RG
Oncotarget; 2018 Nov; 9(92):36530-36541. PubMed ID: 30559935
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications.
Li Q; Zhang Z; Fan Y; Zhang Q
Front Genet; 2020; 11():562868. PubMed ID: 33510766
[TBL] [Abstract][Full Text] [Related]
24. The epigenetic origin of aneuploidy.
Herrera LA; Prada D; Andonegui MA; Dueñas-González A
Curr Genomics; 2008 Mar; 9(1):43-50. PubMed ID: 19424483
[TBL] [Abstract][Full Text] [Related]
25. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
26. Epigenetics of Sepsis.
Binnie A; Tsang JLY; Hu P; Carrasqueiro G; Castelo-Branco P; Dos Santos CC
Crit Care Med; 2020 May; 48(5):745-756. PubMed ID: 32167492
[TBL] [Abstract][Full Text] [Related]
27. Molecular epigenetics and genetics in neuro-oncology.
Nagarajan RP; Costello JF
Neurotherapeutics; 2009 Jul; 6(3):436-46. PubMed ID: 19560734
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic enzyme mutations as mediators of anti-cancer drug resistance.
Chen S; Zhao Y; Liu S; Zhang J; Assaraf YG; Cui W; Wang L
Drug Resist Updat; 2022 Mar; 61():100821. PubMed ID: 35219075
[TBL] [Abstract][Full Text] [Related]
29. Influences of polycyclic aromatic hydrocarbon on the epigenome toxicity and its applicability in human health risk assessment.
Das DN; Ravi N
Environ Res; 2022 Oct; 213():113677. PubMed ID: 35714684
[TBL] [Abstract][Full Text] [Related]
30. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
Xu H; Yu H; Jin R; Wu X; Chen H
Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
[TBL] [Abstract][Full Text] [Related]
31. The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.
Takacs M; Segesdi J; Banati F; Koroknai A; Wolf H; Niller HH; Minarovits J
Mediterr J Hematol Infect Dis; 2009 Nov; 1(2):e2009012. PubMed ID: 21416002
[TBL] [Abstract][Full Text] [Related]
32. Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors.
La Madrid AM; Kieran MW
Curr Cancer Drug Targets; 2018; 18(1):57-64. PubMed ID: 28176655
[TBL] [Abstract][Full Text] [Related]
33. Unraveling the Progression of Colon Cancer Pathogenesis Through Epigenetic Alterations and Genetic Pathways.
Abolghasemi Fard A; Mahmoodzadeh A
Cureus; 2024 May; 16(5):e59503. PubMed ID: 38826873
[TBL] [Abstract][Full Text] [Related]
34. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
Morrison AJ
FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
[TBL] [Abstract][Full Text] [Related]
35. Ependymal Tumors: Overview of the Recent World Health Organization Histopathologic and Genetic Updates with an Imaging Characteristic.
Soni N; Ora M; Bathla G; Desai A; Gupta V; Agarwal A
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844368
[TBL] [Abstract][Full Text] [Related]
36. Weighing ependymoma as an epigenetic disease.
Stuckert A; Bertrand KC; Wang P; Smith A; Mack SC
J Neurooncol; 2020 Oct; 150(1):57-61. PubMed ID: 32964355
[TBL] [Abstract][Full Text] [Related]
37. How epigenetics impacts on human diseases.
Farsetti A; Illi B; Gaetano C
Eur J Intern Med; 2023 Aug; 114():15-22. PubMed ID: 37277249
[TBL] [Abstract][Full Text] [Related]
38. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
[TBL] [Abstract][Full Text] [Related]
39. The significance of epigenetic alterations in lung carcinogenesis.
Brzeziańska E; Dutkowska A; Antczak A
Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
[TBL] [Abstract][Full Text] [Related]
40. Advances in the classification and treatment of pediatric brain tumors.
Fangusaro J; Bandopadhayay P
Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
